Related Experiment Video
Updated: Mar 19, 2026

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
[Relationship of menopause with cardiovascular disease and related metabolic disorders]
1Division of Non-Communicable Disease Control & Community Health, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Objective:
To explore the associations of menopause with cardiovascular disease (CVD) and related metabolic disorders (including hypertension, diabetes or higher blood sugar, obesity, dyslipidemia) in Chinese females aged 45-59 years .
Methods:
Data were acquired from a national cross-sectional survey conducted in 2013, China, which was also the second follow-up survey of China Health and Retirement Longitudinal Study (CHARLS). In the study, 4 702 Chinese perimenopausal women aged 45-59 years were enrolled, including 1 769 premenopausal women and 2 933 postmenopausal women. Information was collected from questionnaires of health status and functioning and physical examination. General liner models were employed to calculate age-adjusted or age-and-body-mass-index-adjusted or multiple-factor-adjusted means and their 95% confidence intervals (95% CIs) of cardiovascular risk factors (CRFs). The comparisons of CVD and its risk factors according to menopausal status, and calculation of adjusted odds ratios (ORs) and their 95%CIs for the associations of menopause with CVD and its risk factors were performed by multivariate Logistic regression models separately.
Results:
After adjustment for age and other confounders (including body mass index, marriage, education, current smoking, drink alcohol more than once per month), statistically significant associations of menopause with cardiovascular disease, which referred to having a history of heart disease or stroke in this study,were observed in the participants (OR=1.34,95%CI: 1.04-1.74); prevalence of hypertension (OR=1.42, 95%CI: 1.10-1.84), prevalence of CRFs clustering number≥2 (OR=1.31, 95%CI: 1.02-1.68) and average waist circumference level (87.11 cm, 95%CI: 86.81-87.42 cm in post-menopausal group vs. 86.41 cm, 95%CI: 85.99-86.84 cm in premenopausal group) were presented higher in postmenopausal group, compared with the premenopausal one. However, diabetes or higher blood sugar (OR= 0.96, 95%CI: 0.60-1.52), dyslipidemia (OR= 0.84, 95%CI: 0.59-1.20) and obesity (OR=1.06, 95%CI: 0.86-1.32) were not shown significantly statistically related to menopause, after excluding effect of age and other confounders.
Conclusion:
Postmenopausal women in China had worse CRFs profile than the premenopausal ones, which implied menopause might aggravate the CRFs epidemic and increase the risk of cardiovascular disease beyond effects of aging, which would increase the CVD burden during and after their middle ages.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Menopause
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Disorders of the Female Reproductive System
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...